Contents


Foreword Riccardo Lencioni


Director, Division of Diagnostic Imaging and Intervention, Department of Hepatology and Liver Transplantation, Pisa University Hospital


Hepatology Hepatocellular Carcinoma


New Treatments for Hepatocellular Carcinoma Cornelia Pfrepper1


and Jean-François Dufour1,2


1. University Clinic of Visceral Surgery and Medicine, Bern University Hospital; 2. Hepatology Department of Clinical Research, University of Bern


Hepatitis


Hepatitis A Vaccines – Impact of Universal Childhood Vaccination Programmes Daniel Shouval,1


Mikhail Mikhaylov2 and Koen Van Herck3,4


1. Liver Unit, Hadassah–Hebrew University Medical Center, Jerusalem; 2. Institute of Poliomyelitis and Viral Encephalitides, Moscow; 3. Vaccine & Infectious Disease Institute, University of Antwerp; 4. Department of Public Health, Ghent University


Hepatitis A and B Vaccination in Elderly Travellers Pierre Van Damme,1


Roman Chlibek2 84 and Emmet B Keeffe3


1. Faculty of Medicine, Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp; 2. Faculty of Military Health Sciences, University of Defense, Hradec Kralove; 3. Stanford University Medical Center, Palo Alto


Liver Fibrosis


Non-invasive Markers of Liver Fibrosis Guillermo Fernández-Varo1


93 and Wladimiro Jiménez1,2


1. Biochemistry and Molecular Genetics Service; 2. Department of Physiology I, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona


Upper Gastrointestinal Tract


Non-erosive Reflux Disease – What We Know So Far Edoardo Savarino,1,2


Lorenzo Gemignani,1 and Vincenzo Savarino1


1. Division of Gastroenterology, Department of Internal Medicine, University of Genoa; 2. Division of Gastroenterology, IRCCS Istituto Clinico Humanitas


Inflammatory Bowel Disease


Report of the Falk Satellite Symposium at the 6th European Crohn’s and Colitis Organisation Congress Update on Treatment Options in Inflammatory Bowel Disease – New Aspects for Established Therapies, New Candidates for the Future


Christine Vetter Medical Writer


Reviewed for scientific accuracy by Volker Groß,1 Wolfgang Kruis2 and Jürgen Schölmerich3


1. Klinikum St Marien, Department of Internal Medicine II, Amberg; 2. Evangelisches Krankenhaus Kalk, Department of Internal Medicine, Cologne; 3. Medical Director (Board Chairman), Hospital of the Goethe University Frankfurt


68 EUROPEAN GASTROENTEROLOGY & HEPATOLOGY REVIEW 104 98 Pietro Dulbecco,1 Simona Inferrera,1 Alberto Malesci2 77 74 72


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84